Adaptimmune Therapeutics plc
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | — | -604.0% | -609.5% |
| FY2023 | — | -231.8% | -188.9% |
| FY2024 | 100.0% | -38.6% | -39.8% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | — | -604.0% | -609.5% |
| FY2023 | — | -231.8% | -188.9% |
| FY2024 | 100.0% | -38.6% | -39.8% |